Spero Therapeutics, Inc. (SPRO)
NASDAQ: SPRO · Real-Time Price · USD
1.200
-0.030 (-2.44%)
Sep 28, 2026, 2:34 PM EDT - Market open
Spero Therapeutics Employees
Spero Therapeutics had 25 employees as of December 31, 2025. The number of employees decreased by 7 or -21.88% compared to the previous year.
Employees
25
Change (1Y)
-7
Growth (1Y)
-21.88%
Revenue / Employee
$1,879,880
Profits / Employee
$295,320
Market Cap
69.88M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 25 | -7 | -21.88% |
| Dec 31, 2024 | 32 | -14 | -30.43% |
| Dec 31, 2023 | 46 | 11 | 31.43% |
| Dec 31, 2022 | 35 | -111 | -76.03% |
| Dec 31, 2021 | 146 | 57 | 64.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Champions Oncology | 214 |
| Fortress Biotech | 78 |
| Verrica Pharmaceuticals | 76 |
| Connect Biopharma Holdings | 64 |
| RenovoRx | 17 |
| Cingulate | 14 |
| MAIA Biotechnology | 13 |
| Aldeyra Therapeutics | 6 |
SPRO News
- 13 days ago - Spero Therapeutics Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 14 days ago - Spero Therapeutics price target raised to $6 from $5 at H.C. Wainwright - TheFly
- 24 days ago - Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 25 days ago - Spero Therapeutics to Present at H.C. Wainwright 28th Annual Global Investment Conference - GlobeNewsWire
- 4 weeks ago - Spero Therapeutics files $300M mixed securities shelf - TheFly
- 4 weeks ago - Spero Therapeutics Registration statement: Registration filing - Filings
- 6 weeks ago - Spero Therapeutics Earnings Call Transcript: Q2 2026 - Transcripts
- 6 weeks ago - Spero Therapeutics Quarterly report: Q2 2026 - Filings